General Information of DTT (ID: TTIS4OW)

DTT Name Phosphodiesterase 8 (PDE8) DTT Info
Gene Name PDE8A

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Patented Agent(s)
Investigative Drug(s)
6 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
AC1M1SP5 DMEW5LD N. A. N. A. Patented [1]
BC11-28 DMTWIE2 N. A. N. A. Patented [1]
US8846654, 11 DMRUTJZ N. A. N. A. Patented [2]
US8846654, 251 DMML258 N. A. N. A. Patented [2]
US8846654, 294 DMP3RCH N. A. N. A. Patented [2]
US9493447, 1001 DM4MJ3U N. A. N. A. Patented [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Patented Agent(s)
2 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
PF-04957325 DMPEZKT Inflammation 1A00-CA43.1 Investigative [4]
PF-4957325-00 DMV4P7S Inflammation 1A00-CA43.1 Investigative [5]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Inhibitors of phosphodiesterase 11 (PDE11). US9173884.
2 Therapeutic applications in the cardiovascular field of quinazolinedione derivatives. US8846654.
3 Optically active PDE10 inhibitor. US9493447.
4 Differential Expression and Function of PDE8 and PDE4 in Effector T cells: Implications for PDE8 as a Drug Target in Inflammation.Front Pharmacol. 2016 Aug 23;7:259.
5 PDE8 regulates rapid Teff cell adhesion and proliferation independent of ICER. PLoS One. 2010 Aug 9;5(8):e12011.